Vivesto is focused on developing new treatments for patients with advanced and hard-to-treat cancers. The company develops projects with the potential to offer novel therapeutic options in areas of significant medical need.
Vivesto has the capacity and proven experience to take product candidates from early-stage development to clinical proof-of-concept. Late-stage development and commercialization are expected to occur through partnerships, but niche products for clearly defined indications may be commercialized independently.